Literature DB >> 14271817

SEROLOGICAL STUDIES IN KERATOPLASTY.

E NELKEN, D NELKEN.   

Abstract

Keywords:  ANTIBODIES; ANTIGENS; CORNEA; CORNEAL OPACITY; CORNEAL TRANSPLANTATION; HEMAGGLUTINATION; RABBITS; TRANSPLANTATION IMMUNOLOGY

Mesh:

Substances:

Year:  1965        PMID: 14271817      PMCID: PMC506087          DOI: 10.1136/bjo.49.3.159

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  The serological specificity of the cornea.

Authors:  D NELKEN; E NELKEN
Journal:  Immunology       Date:  1962-09       Impact factor: 7.397

2.  Accelerated skin graft rejection in humans preimmunized with homologous peripheral leukocytes.

Authors:  E A FRIEDMAN; J W RETAN; D C MARSHALL; L HENRY; J P MERRILL
Journal:  J Clin Invest       Date:  1961-12       Impact factor: 14.808

3.  Late clouding of experimental corneal grafts.

Authors:  E NELKEN; D NELKEN; I C MICHAELSON; J GUREVITCH
Journal:  Arch Ophthalmol       Date:  1961-04

4.  Corneal transplants and blood types; a clinical study.

Authors:  P MEHRI; B BECKER; R OGLESBY
Journal:  Am J Ophthalmol       Date:  1959-01       Impact factor: 5.258

5.  Corneal donor selection by blood type.

Authors:  W H HAVENER; G T STINE; L L WEISS
Journal:  AMA Arch Ophthalmol       Date:  1958-09
  5 in total
  3 in total

1.  [Studies on serum-antibodies after keratoplasty. II. Haemagglutinating antibodies].

Authors:  H J Meyer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1968

2.  [Studies on serum-antibodies after keratoplasty. 3. Complement-fixing antibodies].

Authors:  H J Meyer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1969

3.  Circulating cornea-specific antibodies in corneal disease and cornea transplantation.

Authors:  M J Jager; A Vos; S Pasmans; R Hoekzema; L Broersma; R van der Gaag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-02       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.